AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19033608 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy restriction (ER)
Number of subjects: 13
Study 19033608 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid and energy restriction (F+ER)
Number of subjects: 13
Study 19033608 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary restriction (ER and F+ER)
Number of subjects: 13
Study 19033608 — intervention group
Group type: EXPERIMENTAL
Intervention: Refeeding after exercise
Number of subjects: 13
Study 16809897 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of iron sucrose
Number of subjects: 12
Study 14722005 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated Symmetry anastomoses
Number of subjects: 50
Study 14722005 — intervention group
Group type: COMPARATOR
Intervention: Conventionally hand-sewn anastomoses
Number of subjects: 50
Study 12052450 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive, resistive back‐strengthening exercises
Number of subjects: 50
Study 12052450 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercises)
Number of subjects: 50
Study 9822138 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril
Number of subjects: 0
Study 9822138 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 0
Study 8279593 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief reminder letter
Number of subjects: 0
Study 8279593 — intervention group
Group type: COMPARATOR
Intervention: No reminder (Control)
Number of subjects: 0
Study 8279593 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counseling
Number of subjects: 0
Study 8279593 — intervention group
Group type: EXPERIMENTAL
Intervention: Letter suggesting a preventive office visit
Number of subjects: 0
Study 8279593 — intervention group
Group type: EXPERIMENTAL
Intervention: Second reminder
Number of subjects: 0
Study 3051509 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine
Number of subjects: 203
Study 3051509 — intervention group
Group type: COMPARATOR
Intervention: Histamine
Number of subjects: 203
Study 30058945 — intervention group
Group type: EXPERIMENTAL
Intervention: Upward social comparison to a friend's romantic relationship
Number of subjects: 0
Study 30058945 — intervention group
Group type: EXPERIMENTAL
Intervention: Downward social comparison to a friend's romantic relationship
Number of subjects: 0
Study 28739539 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive medication review during hospital stay
Number of subjects: 8
Study 28739539 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive medication review during hospital stay with active follow-up into primary care
Number of subjects: 8
Study 28739539 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 8
Study 25938655 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral and nutritional treatment
Number of subjects: 78
Study 25938655 — intervention group
Group type: COMPARATOR
Intervention: Education and attention control treatment
Number of subjects: 78
Study 23596814 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Traditional Chinese Medicine (TCM) and Western Medicine
Number of subjects: 26
Study 23596814 — intervention group
Group type: COMPARATOR
Intervention: Western Medicine
Number of subjects: 26
Study 21830513 — intervention group
Group type: EXPERIMENTAL
Intervention: Light ceiling and light walls
Number of subjects: 0
Study 21830513 — intervention group
Group type: COMPARATOR
Intervention: Floor color
Number of subjects: 0
Study 21830513 — intervention group
Group type: COMPARATOR
Intervention: Lightness contrast between ceiling and walls
Number of subjects: 0
Study 21830513 — intervention group
Group type: COMPARATOR
Intervention: Physical height
Number of subjects: 0
Study 21830513 — intervention group
Group type: COMPARATOR
Intervention: Physical width
Number of subjects: 0
Study 21830513 — intervention group
Group type: COMPARATOR
Intervention: Ceiling lightness
Number of subjects: 0
Study 18930251 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (200 mg eicosapentaenoic acid plus 1 g docosahexaenoic acid daily)
Number of subjects: 180
Study 18930251 — intervention group
Group type: COMPARATOR
Intervention: Placebo (soybean oil)
Number of subjects: 180
Study 18930251 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 180
Study 18930251 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 17078116 — intervention group
Group type: EXPERIMENTAL
Intervention: Restricted fluids (less than 2 litres water and 77 mmol sodium for 24 h after surgery)
Number of subjects: 80
Study 17078116 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative fluid regimen (3 litres water and 154 mmol sodium per day for as long as necessary)
Number of subjects: 80
Study 17078116 — intervention group
Group type: EXPERIMENTAL
Intervention: Restricted fluids
Number of subjects: 80
Study 17078116 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative fluid regimen
Number of subjects: 80
Study 15113381 — intervention group
Group type: EXPERIMENTAL
Intervention: MonoRho (300 micro g) intravenously
Number of subjects: 18
Study 15113381 — intervention group
Group type: EXPERIMENTAL
Intervention: MonoRho (300 micro g) intramuscularly
Number of subjects: 18
Study 15113381 — intervention group
Group type: EXPERIMENTAL
Intervention: MonoRho (300 micro g) intravenously and intramuscularly
Number of subjects: 18
Study 11728663 — intervention group
Group type: COMPARATOR
Intervention: Electrosurgery
Number of subjects: 30
Study 11728663 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparosonic technique
Number of subjects: 30
Study 9070553 — intervention group
Group type: EXPERIMENTAL
Intervention: Directional atherectomy
Number of subjects: 1012
Study 9070553 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous transluminal coronary angioplasty
Number of subjects: 1012
Study 7698134 — intervention group
Group type: EXPERIMENTAL
Intervention: High caloric fluid (n = 9)
Number of subjects: 22
Study 7698134 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 13)
Number of subjects: 22
Study 3666688 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosterone (CS) treatment
Number of subjects: 0
Study 3666688 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P) treatment
Number of subjects: 0
Study 31282492 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Psychoeducation (PE)
Number of subjects: 96
Study 31282492 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 96
Study 28544391 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience Sampling Method (ESM)
Number of subjects: 0
Study 28544391 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended care (mix of face-to-face and ESM)
Number of subjects: 0
Study 25920302 — intervention group
Group type: EXPERIMENTAL
Intervention: Rue-si-dad-ton exercise (1 hour per day for 4 days)
Number of subjects: 37
Study 25920302 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 37
Study 23497845 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyes that developed POAG
Number of subjects: 441
Study 23497845 — intervention group
Group type: COMPARATOR
Intervention: Eyes that did not develop POAG
Number of subjects: 441
Study 23497845 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyes with an optic disc POAG endpoint
Number of subjects: 441
Study 23497845 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyes with worse baseline visual field pattern standard deviation and higher intraocular pressure during follow-up
Number of subjects: 441
Study 23497845 — intervention group
Group type: COMPARATOR
Intervention: Eyes in which POAG did not develop
Number of subjects: 441
Study 22208409 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Preventive Treatment for malaria (IPTi)
Number of subjects: 24
Study 22208409 — intervention group
Group type: COMPARATOR
Intervention: Control (no IPTi)
Number of subjects: 24
Study 22208409 — intervention group
Group type: EXPERIMENTAL
Intervention: IPTi
Number of subjects: 24
Study 19332196 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination niacin-simvastatin (simvastatin 20 mg/Niacin-ER 2G)
Number of subjects: 75
Study 19332196 — intervention group
Group type: COMPARATOR
Intervention: High-dose simvastatin (80 mg)
Number of subjects: 75
Study 19332196 — intervention group
Group type: COMPARATOR
Intervention: Moderate-dose simvastatin (20 mg)
Number of subjects: 75
Study 16432596 — intervention group
Group type: EXPERIMENTAL
Intervention: MMR vaccination
Number of subjects: 527
Study 15191036 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol 400 microg
Number of subjects: 37
Study 15191036 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 80 microg
Number of subjects: 37
Study 15191036 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 11167173 — intervention group
Group type: COMPARATOR
Intervention: Double-lumen tube (DLT)
Number of subjects: 35
Study 11167173 — intervention group
Group type: EXPERIMENTAL
Intervention: Wiruthan bronchial blocker (BB) - left mainstem bronchus (BBL)
Number of subjects: 35
Study 11167173 — intervention group
Group type: EXPERIMENTAL
Intervention: Wiruthan bronchial blocker (BB) - right mainstem bronchus (BBR)
Number of subjects: 35
Study 9429044 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopentone (9 mg.kg‐1 lean body mass)
Number of subjects: 30
Study 8310278 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician-led primary home care intervention
Number of subjects: 0
Study 8310278 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 0
Study 3553435 — intervention group
Group type: EXPERIMENTAL
Intervention: AMSA-OAP
Number of subjects: 242
Study 3553435 — intervention group
Group type: COMPARATOR
Intervention: Ad-OAP
Number of subjects: 242
Study 31898309 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral stress management (CBSM)
Number of subjects: 192
Study 31898309 — intervention group
Group type: COMPARATOR
Intervention: Health promotion (HP)
Number of subjects: 192
Study 30587468 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention by pharmacist
Number of subjects: 384
Study 26602699 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine adhesive patch
Number of subjects: 261
Study 26602699 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 261
Study 25715856 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia counselling (MC)
Number of subjects: 0
Study 25715856 — intervention group
Group type: COMPARATOR
Intervention: Conventional counselling (CC)
Number of subjects: 0
Study 25715856 — intervention group
Group type: COMPARATOR
Intervention: MDI-only users
Number of subjects: 0
Study 23052644 — intervention group
Group type: EXPERIMENTAL
Intervention: High-pitch spiral CTCA
Number of subjects: 459
Study 23052644 — intervention group
Group type: COMPARATOR
Intervention: Narrow-window sequential CTCA
Number of subjects: 459
Study 23052644 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide-window sequential CTCA
Number of subjects: 459
Study 23052644 — intervention group
Group type: COMPARATOR
Intervention: Retrospective spiral CTCA
Number of subjects: 459
Study 20940450 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-label ivabradine use (n = 30)
Number of subjects: 60
Study 20940450 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 30)
Number of subjects: 60
Study 17536194 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-food meal (burger, French fries, root beer with high fructose corn syrup)
Number of subjects: 6
Study 17536194 — intervention group
Group type: EXPERIMENTAL
Intervention: Organic beef meal (organic foods, root beer with sucrose)
Number of subjects: 6
Study 17536194 — intervention group
Group type: EXPERIMENTAL
Intervention: Turkey meal (turkey sandwich, granola with organic foods, organic orange juice)
Number of subjects: 6
Study 15180168 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT) for 12 weeks
Number of subjects: 197
Study 15180168 — intervention group
Group type: COMPARATOR
Intervention: Control group (smokers)
Number of subjects: 197
Study 11511120 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase
Number of subjects: 0
Study 11511120 — intervention group
Group type: COMPARATOR
Intervention: Lanoteplase
Number of subjects: 0
Study 11511120 — intervention group
Group type: EXPERIMENTAL
Intervention: Germany
Number of subjects: 0
Study 11511120 — intervention group
Group type: EXPERIMENTAL
Intervention: U.S.
Number of subjects: 0
Study 9572097 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing an emotional film of 10 min
Number of subjects: 40
Study 9572097 — intervention group
Group type: EXPERIMENTAL
Intervention: Performing standardized physical exercise of modest intensity up to a heartbeat of 170 b/min
Number of subjects: 40
Study 9572097 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of viewing an emotional film and exercise (order conditions 1 + 2)
Number of subjects: 40
Study 9572097 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of exercise and viewing an emotional film (order conditions 2 + 1)
Number of subjects: 40
Study 7920869 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise 1 (fixed 100 Watt load, unstandardised diet and activity)
Number of subjects: 37
Study 7920869 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise 2 (fasted, standardised to 45% VO2max)
Number of subjects: 37
Study 7920869 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise 3 (fed, standardised to 45% VO2max)
Number of subjects: 37
Study 3386506 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-held weights (HW)
Number of subjects: 12
Study 3386506 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist weights (WW)
Number of subjects: 12
Study 3386506 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle weights (AW)
Number of subjects: 12
Study 3386506 — intervention group
Group type: COMPARATOR
Intervention: Hand-held weights (HW) vs No weights (NW)
Number of subjects: 12
Study 3386506 — intervention group
Group type: COMPARATOR
Intervention: No weights (NW)
Number of subjects: 12
Study 3386506 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-held weights (HW) and Wrist weights (WW)
Number of subjects: 12
Study 30935327 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmental and distal dry needling (DN)
Number of subjects: 65
Study 30935327 — intervention group
Group type: COMPARATOR
Intervention: Non-thrust manipulation (NTM)
Number of subjects: 65
Study 30935327 — intervention group
Group type: EXPERIMENTAL
Intervention: Both DN and NTM
Number of subjects: 65
Study 29454327 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support program (monthly group meetings facilitated by a trained peer leader for 12 months)
Number of subjects: 273
Study 29454327 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support program
Number of subjects: 273
Study 29454327 — intervention group
Group type: COMPARATOR
Intervention: Control arm (not specified in detail)
Number of subjects: 273
Study 26808857 — intervention group
Group type: EXPERIMENTAL
Intervention: Regulated Group (RG) - 6 weeks of training with training load regulated by mean height of CMJ with MID
Number of subjects: 18
Study 26808857 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - preplanned training
Number of subjects: 18
Study 24974855 — intervention group
Group type: EXPERIMENTAL
Intervention: Early induction (n = 65)
Number of subjects: 129
Study 24974855 — intervention group
Group type: COMPARATOR
Intervention: Expectant management (n = 64)
Number of subjects: 129
Study 24974855 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 129
Study 22218933 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive case management (ICM)
Number of subjects: 80
Study 22218933 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 80
Study 21154018 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based physical activity intervention
Number of subjects: 47
Study 21154018 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 47
Study 17347579 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrate anticoagulation
Number of subjects: 10
Study 17347579 — intervention group
Group type: COMPARATOR
Intervention: Normal temperature HD with dalteparin
Number of subjects: 10
Study 17347579 — intervention group
Group type: COMPARATOR
Intervention: Low temperature HD with dalteparin
Number of subjects: 10
Study 17199929 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioadhesive benzalkonium chloride (BZK) gel
Number of subjects: 240
Study 17199929 — intervention group
Group type: COMPARATOR
Intervention: Nonoxynol-9 (NP-9) gel
Number of subjects: 240
Study 12799750 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency rTMS (20 Hz) over the left dorsolateral prefrontal cortex (LDLPFC)
Number of subjects: 30
Study 12799750 — intervention group
Group type: EXPERIMENTAL
Intervention: Low frequency rTMS (1 Hz) over the right dorsolateral prefrontal cortex (RDLPFC)
Number of subjects: 30
Study 12799750 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30
Study 12799750 — intervention group
Group type: EXPERIMENTAL
Intervention: Real stimulation procedures (both high and low frequency rTMS)
Number of subjects: 30
Study 12799750 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with less severe deficits in psychomotor speed and concentration
Number of subjects: 30
Study 10586392 — intervention group
Group type: EXPERIMENTAL
Intervention: Azimilide dihydrochloride, intravenous doses of 4.5 to 9 mg/kg over 60 minutes, and 4.5 mg/kg over 15 or 30 minutes
Number of subjects: 68
Study 10586392 — intervention group
Group type: COMPARATOR
Intervention: Control not specified
Number of subjects: 68
Study 8835347 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 ml vaccine, administered three times (first dose, second dose at 1 month, third dose at 6 months)
Number of subjects: 67
Study 8835347 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 ml vaccine, administered three times (first dose, second dose at 1 month, third dose at 6 months)
Number of subjects: 67
Study 8835347 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vaccination)
Number of subjects: 67
Study 8835347 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccinated children
Number of subjects: 67
Study 1895263 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone treatment in glucocorticoid sensitive patients
Number of subjects: 0
Study 1895263 — intervention group
Group type: COMPARATOR
Intervention: Control patients (not specified what treatment they received)
Number of subjects: 0
Study 7037046 — intervention group
Group type: EXPERIMENTAL
Intervention: pindolol eye drops 0.5%
Number of subjects: 24
Study 7037046 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study 30691425 — intervention group
Group type: EXPERIMENTAL
Intervention: CATS services plus standard of care
Number of subjects: 94
Study 30691425 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 94
Study 28422869 — intervention group
Group type: EXPERIMENTAL
Intervention: Jianpi Qingchang decoction (JQD)
Number of subjects: 120
Study 28422869 — intervention group
Group type: COMPARATOR
Intervention: 5-amino salicylic acid
Number of subjects: 120
Study 25488897 — intervention group
Group type: EXPERIMENTAL
Intervention: unsedated transnasal endoscopy in a mobile research van (muTNE)
Number of subjects: 459
Study 25488897 — intervention group
Group type: EXPERIMENTAL
Intervention: unsedated transnasal endoscopy in a hospital outpatient endoscopy suite (huTNE)
Number of subjects: 459
Study 25488897 — intervention group
Group type: COMPARATOR
Intervention: sedated esophagogastroduodenoscopy (sEGD)
Number of subjects: 459
Study 23826843 — intervention group
Group type: EXPERIMENTAL
Intervention: Micropercutaneous nephrolithotomy (microperc)
Number of subjects: 70
Study 23826843 — intervention group
Group type: COMPARATOR
Intervention: Retrograde intrarenal surgery (RIRS)
Number of subjects: 70
Study 21062335 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics at initial therapy
Number of subjects: 38
Study 21062335 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics at re-treatment
Number of subjects: 38
Study 19406269 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II (aortic regurgitation with LV hypertrophy and preserved systolic function)
Number of subjects: 24
Study 19406269 — intervention group
Group type: EXPERIMENTAL
Intervention: Group III (aortic regurgitation with LV dysfunction)
Number of subjects: 24
Study 19406269 — intervention group
Group type: EXPERIMENTAL
Intervention: Group IV (end-stage HF)
Number of subjects: 24
Study 19406269 — intervention group
Group type: COMPARATOR
Intervention: Group I (control with normal LV function)
Number of subjects: 24
Study 17295333 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous (SQ) enoxaparin 1 mg/kg
Number of subjects: 33
Study 17295333 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental intravenous (IV) enoxaparin (0.3‐0.5 mg/kg)
Number of subjects: 33
Study 17295333 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ enoxaparin without IV dosing
Number of subjects: 33
Study 15149341 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose (100 mg over 5 minutes)
Number of subjects: 20
Study 15149341 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 20
Study 11144997 — intervention group
Group type: EXPERIMENTAL
Intervention: SCH 48461 6.25 to 400 mg
Number of subjects: 190
Study 11144997 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 40 mg/day
Number of subjects: 190
Study 11144997 — intervention group
Group type: EXPERIMENTAL
Intervention: SCH 48461 (1 mg to 400 mg)
Number of subjects: 190
Study 11144997 — intervention group
Group type: EXPERIMENTAL
Intervention: SCH 48461 (25 mg to 400 mg)
Number of subjects: 190
Study 11144997 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study 9505058 — intervention group
Group type: EXPERIMENTAL
Intervention: ipsapirone 15 mg per day
Number of subjects: 65
Study 9505058 — intervention group
Group type: EXPERIMENTAL
Intervention: ipsapirone 22.5 mg per day
Number of subjects: 65
Study 9505058 — intervention group
Group type: COMPARATOR
Intervention: lorazepam 3 mg per day
Number of subjects: 65
Study 9505058 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 65
Study 7829793 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft surgery within 24 hours after entry or after coronary angioplasty
Number of subjects: 3339